Kexing Biopharm’s overseas commercial product

Recently, Kexing Biopharm announced that its overseas drug—Paclitaxel for Injection (Albumin-bound) (brand name: Apexelsin®)—has received marketing approval from the Philippine Food and Drug Administration.Compared with conventional paclitaxel injections and liposomal...